Alzheimer's Disease & Cannabinoid Medicine

An Alzheimer’s diagnosis is life-changing for the person with the disease, as well as their families & friends.

While there are currently no treatments available to slow or stop the progression of Alzheimer’s disease, there are several medications and non-pharmacological interventions that can temporarily improve the symptoms in some people. There is also a significant amount of research being conducted.

In the first clinical trial to show that a cannabinoid can decrease agitation in Alzheimer’s disease, researchers at Sunnybrook Health Sciences Centre in Toronto found: “A robust and significant decrease in agitation during nabilone compared to placebo, a significant overall improvement and a decrease in caregiver distress.”

To read the full article, google search “neurologylive.com + Krista Lanctot.”